Concepedia

Therapy Duration Optimization

Therapy Duration Optimization is a clinical decision-making framework that determines the minimal effective duration of antiviral treatment in chronic hepatitis management to maximize sustained virological response while minimizing drug exposure, adverse effects, and resistance risk.

67

Publications

6.4K

Citations

586

Authors

280

Institutions

Publications per year

2017–2026

21

Parents

Publications

67

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

Ira M. Jacobson, John G. McHutchison, Geoffrey Dusheiko et al. · New England Journal of Medicine · 2011 · 2.4K citations · Full text

, , +17

Peginterferon Alfa-2b and Ribavirin for 12 vs. 24 Weeks in HCV Genotype 2 or 3

Alessandra Mangia, Rosanna Santoro, Nicola Minerva et al. · New England Journal of Medicine · 2005 · 839 citations · Full text

, , +17

Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial

Ming‐Lung Yu, Chia‐Yen Dai, Jee‐Fu Huang et al. · Hepatology · 2008 · 278 citations

, , +17

Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial

Alessandra Mangia, Nicola Minerva, Donato Bacca et al. · Hepatology · 2007 · 250 citations · Full text

, , +17

Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1‐infected patients without cirrhosis: OPTIMIST‐1, a phase 3, randomized study

Paul Y. Kwo, Norman Gitlin, Ronald Nahass et al. · Hepatology · 2016 · 189 citations · Full text

, , +16

1–5 of 67

Authors

586

  1. JG
    John G. McHutchison

    Gilead Sciences (United States), United States

    7 publications · 2.6K citations

    7

    h-index

  2. AM
    Alessandra Mangia

    Casa Sollievo della Sofferenza, Italy

    4 publications · 1.2K citations

    5

    h-index

  3. CS
    Christoph Sarrazin

    Goethe University Frankfurt, Germany

    3 publications · 159 citations

    3

    h-index

  4. AA
    Angelo Andriulli

    Casa Sollievo della Sofferenza, Italy

    3 publications · 1.1K citations

    3

    h-index

  5. DB
    Donato Bacca

    Casa Sollievo della Sofferenza, Italy

    3 publications · 1.1K citations

    3

    h-index

1–5 of 586

Institutions

280

  1. Goethe University Frankfurt

    Frankfurt am Main, Germany

    6 h-index

    13 publications

    3K citations

  2. Gilead Sciences (United States)

    Foster City, United States

    5 h-index

    29 publications

    1.1K citations

  3. Casa Sollievo della Sofferenza

    San Giovanni Rotondo, Italy

    5 h-index

    16 publications

    4.8K citations

  4. Imperial College London

    London, United Kingdom

    4 h-index

    9 publications

    249 citations

  5. Charité - Universitätsmedizin Berlin

    Berlin, Germany

    3 h-index

    5 publications

    209 citations

  6. Harvard University

    Cambridge, United States

    3 h-index

    5 publications

    337 citations

  7. University of Foggia

    Foggia, Italy

    3 h-index

    2 publications

    1.1K citations

  8. University of Bristol

    Bristol, United Kingdom

    3 h-index

    14 publications

    1K citations

1–8 of 280

Venues

  1. Hepatology

    12 publications · 1.3K citations

    12

    h-index

  2. Journal of Hepatology

    5 publications · 410 citations

    6

    h-index

  3. Antiviral Therapy

    4 publications · 119 citations

    4

    h-index

  4. Journal of Viral Hepatitis

    3 publications · 125 citations

    3

    h-index

  5. Liver International

    3 publications · 45 citations

    3

    h-index

1–5